¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"bacteriophage immunity"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® bacteriophage ÇÑ±Û ¼¼±ÕÆÄÁö, ¹ÚÅ׸®¿ÀÆÄÁö
¼³¸í   
  ¼¼±Õ¿¡ °¨¿°µÇ¾î ±× ¼¼Æ÷ ³»¿¡¼­¸¸ Áõ½ÄÇϴ ¹ÙÀÌ·¯½º ¼¼±ÕÀ» ¼÷ÁַΠÇϴ ¹ÙÀÌ·¯½º·Î ¼¼±Õ¹ÙÀÌ·¯½º¶ó°íµµ ÇÑ´Ù. Áï, ÇÙ»ê°ú ¼Ò¼öÀÇ È¿¼Ò¸¦ ´Ü¹éÁúÀÇ ²®Áú·Î ½Î°í Àִ °£´ÜÇÑ ±¸Á¶À̸ç, °¢°¢ Æ¯Á¤ÀÇ ¼¼±ÕÁ¾¿¡¸¸ °¨¿°ÇÑ´Ù. ¼¼±Õ¿¡ ±â»ýÇϸ砱Õü¸¦ ³ìÀ̴ ¹ÙÀÌ·¯½ºÀÌ´Ù. À¯Àü ÇüÁúÀÇ È­ÇÐÀû Æ¯¼ºÀ» ¿¬±¸Çϴ µ¥¿¡ ¾´´Ù. ÆÄÁö¿¡´Â DNA¿Í RNA ÆÄÁö°¡ ÀÖÀ¸¸ç, ±âÈ£¿Í ¼ýÀڷΠºÐ·ùÇÑ´Ù. ¼¼±Õ¿¡ °¨¿°µÇ¾î ¼¼±ÕÀ» ¿ëÇØ½Ã۴ °ÍÀ» ¿ë±ÕÆÄÁö¶ó ºÎ¸£¸ç, ¼÷ÁÖ¸¦ ³ìÀÌÁö ¾Ê°í ¼÷ÁÖ À¯Àüü¿¡ µé¾î°¡ °øÁ¸Çϴ °ÍÀ» ÅÛÆÛ·¹ÀÌÆ® ÆÄÁö¶ó ºÎ¸¥´Ù. ¶Ç, µ¿½Ä¹° ¼¼Æ÷¿¡ °¨¿°Çϴ ¹ÙÀÌ·¯½º¸¦ °¢°¢ µ¿¹° ¹ÙÀÌ·¯½º-½Ä¹° ¹ÙÀÌ·¯½º¶ó Çϴµ¥ ´ëÇÏ¿© ¼¼±Õ ¹ÙÀÌ·¯½º¶ó°íµµ ÇÑ´Ù. ¼¼±Õ¿©°ú±â¸¦ Åë°úÇϸ砱¤ÇÐÇö¹Ì°æÀ¸·Î´Â Á÷Á¢ º¼ ¼ö ¾ø´Â ¹Ì¼ÒÇÑ ÀÔÀÚÀÌ´Ù. »ì¾ÆÀִ ¼¼Æ÷ ³»¿¡¼­¸¸ Áõ½ÄÀÌ °¡´ÉÇϰí, ´ë»çȰ¼ºÀ» ³ªÅ¸³»´Â Àϵµ ¾ø´Ù.
¿µ¹® immunity ÇÑ±Û ¸é¿ª
¼³¸í   
  ¸ö¼Ó¿¡ µé¾î¿Â º´¿ø ¹Ì»ý¹°¿¡ ´ëÇ×Çϴ Ç×ü¸¦ »ý»êÇÏ¿© µ¶¼Ò¸¦ ÁßÈ­Çϰųª º´¿ø ¹Ì»ý¹°À» Á׿©¼­ ´ÙÀ½¿¡´Â ±× º´¿¡ °É¸®Áö ¾Êµµ·Ï µÈ »óÅÂ. ¶Ç´Â ±×·± ÀÛ¿ë. º´¿ø¼º¹Ì»ý¹° ¹× ÀÌÁ¾´Ü¹éÁú, ´Ù´çü-ÁöÁú µîÀǠħÀÔ, ¶Ç´Â ÀÌÇü ¼öÇ÷, Á¶Á÷ À̽Ġµî, Æø³Ð°Ô ÀÚ±â ÀÌ¿ÜÀÇ À̹°À̠ħÀÔÇÏ¿´À» ¶§ Àڱ⸦ ¹æÀ§Çϴ »ýü¹ÝÀÀÀ» ¸»ÇÑ´Ù. ¿ø·¡ ÀÏ´Ü °¨¿°Áõ¿¡ °É¸®°í È¸º¹µÇ¸é, Æò»ý ±× º´¿¡ °É¸®Áö ¾Ê´Â ¡®Àç¹ßÇÏÁö ¾Ê´Â Çö»ó¡¯À» ÀǹÌÇÏ¿´Áö¸¸, ÇöÀç´Â »ç¶÷À̳ª µ¿¹°ÀÌ, À̹°ÀǠħÀÔ¿¡ ´ëÇØ, °¢°¢ ´ëÀÀÇÑ Ç×ü¸¦ »ý»êÇÏ¿© ÀúÇ×¼ºÀ» ¾ò´Â »óŸ¦ ¸»ÇÑ´Ù. ¸é¿ª¿¡´Â Å¾¸é¼­ºÎÅÍ °®°í Àִ ÀÚ¿¬¸é¿ª°ú, »ýÈÄ Ç׿ø°ú Á¢ÇϰԠµÊ¿¡ µû¶ó ¾ò¾îÁö´Â È¹µæ¸é¿ªÀÌ ÀÖÀ¸¸ç, È¹µæ¸é¿ª¿¡´Â ´Éµ¿¸é¿ª°ú ¼öµ¿¸é¿ªÀÌ ÀÖ´Ù. ´Éµ¿¸é¿ª¿¡´Â Áúº´ È¸º¹ ÈÄ¿¡ ¾ò¾îÁö´Â º´ÈÄ ¸é¿ª°ú ¹é½Åµî¿¡ ÀÇÇÑ ¿¹¹æÁ¢Á¾ °á°ú·Î ¾ò¾îÁö´Â ÀΰøÀû ¹æ¹ýÀÌ ÀÖ´Ù. ¼öµ¿¸é¿ªÀº ¸é¿ªÇ×ü¸¦ °®´Â Ç÷ûÀ» ÁÖ»çÇØ¼­ ¾òÀ» ¼ö ÀÖ´Ù.
¿µ¹® cell-mediated immunity ÇÑ±Û ¼¼Æ÷¸Å°³¸é¿ª
¼³¸í   
  ¸é¿ªÀ̶õ ½Åü¸¦ ¿ÜºÎÀÇ ¹°Áú·ÎºÎÅÍ º¸È£Çϴ ÇàÀ§¸¦ ¸»ÇÑ´Ù. ¿©±â¿¡´Â Æ¯ÀÌÀû ¸é¿ª°ú ºñƯÀÌÀû ¸é¿ªÀÇ µÎ °¡Áö°¡ ÀÖ´Ù.
  
  ºñƯÀÌÀû ¸é¿ªÀ̶óÇÔÀº Æ¯Á¤ÇÑ ¹°Áú¿¡ °ü°èÇϴ ¸é¿ªÀÌ ¾Æ´Ï¶ó Æ¯Á¤ ´ë»óÀÌ ¾øÀÌ ¸ðµç ¿ÜºÎ ¹°Ã¼¿¡ ÀÛ¿ëÇÒ ¼ö Àִ ¸é¿ªÀ» ¸»ÇÑ´Ù. ¿©±â¿¡´Â ¼Òº¯ÀÇ È帧, ´«¹°ÀÇ È帧, ÇǺÎÀÇ ºñÅõ°ú¼º µîÀÇ ±â°èÀûÀΠ°Íµµ Æ÷ÇԵǰí ÇǼӿ¡ µ¹¾Æ´Ù´Ï´Â ¼¼Æ÷ Áß¿¡¼­ ºñƯÀÌÀûÀ¸·Î ¿ÜºÎÀÇ ¹°ÁúÀ» Æ÷½ÄÇϴ ¼¼Æ÷µé(¿¹¸¦ µé¸é Å«Æ÷½Ä¼¼Æ÷(macrophage)ÀǠȰµ¿µµ Æ÷ÇÔÀÌ µÈ´Ù. ¼¼Æ÷¸Å°³¸é¿ªÀ̶õ Æ¯ÀÌÇÑ ¹°ÁúÀ» °¨ÁöÇÒ ¼ö Àִ ¼¼Æ÷¸¦ »ý¼ºÇϰԠÇÏ¿© ±×°ÍÀ¸·Î ÇÏ¿©±Ý ±× ¹°ÁúÀ» Æ÷½ÄÇϰԠÇϴ °ÍÀ» ¸»ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bacteriophage
    ¹ÚÅ׸®¿ÀÆÄÁö
  • bacteriophage neutralization test
    ¹ÚÅ׸®¿ÀÆÄÁöÁßÈ­½ÃÇè
  • defective bacteriophage
    °á¼Õ¹ÚÅ׸®¿ÀÆÄÁö
  • antibody-mediated immunity
    Ç×ü¸Å°³¸é¿ª
  • antitoxic immunity
    Ç×µ¶¼Ò¸é¿ª
  • artificial active immunity
    Àΰø´Éµ¿¸é¿ª
  • athreptic immunity
    ¹«¿µ¾ç¸é¿ª
  • acquired immunity
    ÈÄõ¸é¿ª
  • active immunity
    ´Éµ¿¸é¿ª
  • adoptive immunity
    Â÷¿ë¸é¿ª, ÀÔ¾ç¸é¿ª
  • concomitant immunity
    ¼ö¹Ý¸é¿ª
  • cross immunity
    ±³Â÷¸é¿ª
  • cell-mediated immunity
    ¼¼Æ÷¸Å°³¸é¿ª
  • cellular immunity
    ¼¼Æ÷¸é¿ª
  • gut immunity
    âÀڸ鿪, Àå°ü¸é¿ª
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bacteriophage
    ¼¼±ÕÆÄÁö, ¹ÚÅ׸®¿ÀÆÄÁö
  • immunity
    ¸é¿ª
  • active immunity
    ´Éµ¿¸é¿ª
  • herd immunity
    ±ºÁý¸é¿ª, Áý´Ü¸é¿ª, ¹«¸®¸é¿ª
  • protective immunity
    ¹æ¾î¸é¿ª
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bacteriophage
    ¼¼±ÕÆÄÁö, ¹ÚÅ׸®¿ÀÆÄÁö
  • bacteriophage typing
    ¹ÚÅ׸®¿ÀÆÄÁöÇüº°, ¹ÚÅ׸®¿ÀÆÄÁöÇü°áÁ¤
  • bacteriophage neutralization test
    ¹ÚÅ׸®¿ÀÆÄÁöÁßÈ­½ÃÇè
  • acquired immunity
    ÈÄõ¸é¿ª
  • active immunity
    ´Éµ¿¸é¿ª
  • adoptive immunity
    ÀÔ¾ç¸é¿ª
  • antibody-mediated immunity
    Ç×ü¸Å°³¸é¿ª
  • antitoxic immunity
    Ç×µ¶¼Ò¸é¿ª
  • artificial active immunity
    Àΰø´Éµ¿¸é¿ª
  • athreptic immunity
    ¹«¿µ¾ç¸é¿ª
  • cell-mediated immunity
    ¼¼Æ÷¸Å°³¸é¿ª
  • cellular immunity
    (¢¡cell-mediated immunity) ¼¼Æ÷¸Å°³¸é¿ª
  • concomitant immunity
    (¢¡infection immunity) °¨¿°¸é¿ª
  • cross immunity
    ±³Â÷¸é¿ª
  • gut immunity
    âÀڸ鿪, Àå°ü¸é¿ª
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Humoral immunity
    ü¾×¼º¸é¿ª(ô÷äûàõØóæ¹)
  • Immunity
    ¸é¿ª¼º(Øóæ¹àõ)
  • T cell immunity
    T¼¼Æ÷¸é¿ª
  • acquired immunity
    ÈÄõ¼º ¸é¿ª, ½Å°æÈ¹µæ¸é¿ª(üòÔðØóæ¹).
  • active immunity
    ´Éµ¿¸é¿ª(ÒöÔÑØóæ¹).
  • antibacterial immunity
    Çױո鿪(¡­Øóæ¹).
  • antibody-mediated immunity
    Ç×ü¸Å°³ ¸é¿ª
  • antimicrobial immunity
    Çױո鿪(¡­Øóæ¹).
  • antitoxic immunity
    Ç×µ¶(¼Ò)¼º ¸é¿ª(ù÷Ô¸áÈàõØóæ¹).
  • antitumor immunity
    Ç×Á¾¾ç(¼º) ¸é¿ª(¡­Øóæ¹).
  • antiviral immunity
    Ç×¹ÙÀÌ·¯½º¸é¿ª(¡­Øóæ¹).
  • antiviral immunity
    Ç×¹ÙÀÌ·¯½º¸é¿ª(~Øóæ¹)
  • artificial active immunity
    Àΰø´Éµ¿¸é¿ª.
  • gut immunity
    Àå°ü¸é¿ª
  • herd immunity
    ±ºÁý¸é¿ª, Áý´Ü¸é¿ª
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bacteriophage
    ¼¼±ÕÆÄÁö, ¹ÚÅ׸®¿ÀÆÄÁö.
  • bacteriophage
    ¼¼±ÕºÐÇØ¹ÙÀÌ·¯½º
  • bacteriophage
    ¹ÚÅ׸®¿ÀÆÄÁö
  • bacteriophage neutralization test
    ¹ÚÅ׸®¿ÀÆÄÁö ÁßÈ­½ÃÇè(¡­ñéûúãËúÐ).
  • bacteriophage neutralization test
    ¹ÚÅ׸®¿ÀÆÄÁöÁßÈ­°Ë»ç
  • bacteriophage typing
    ¹ÚÅ׸®¿ÀÆÄÁöÇüº°¹ý
  • bacteriophage typing
    ¼¼±ÕÆÄ¾ÆÁöÇüº°È­(úþܬûù)
  • acquired immunity
    ÈÄõ¼º ¸é¿ª, ½Å°æÈ¹µæ¸é¿ª(üòÔðØóæ¹).
  • active immunity
    ´Éµ¿¸é¿ª(ÒöÔÑØóæ¹).
  • adoptive immunity
    ÀÔ¾ç¸é¿ª(¡­Øóæ¹).
  • adoptive immunity
    ÀÔ¾ç¸é¿ª(¡­Øóæ¹).
  • adoptive immunity
    ÀÔ¾ç¸é¿ª(¡­Øóæ¹).
  • antibacterial immunity
    Çױո鿪(¡­Øóæ¹).
  • antibody-mediated immunity
    Ç×ü¸Å°³ ¸é¿ª
  • antimicrobial immunity
    Çױո鿪(¡­Øóæ¹).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bacteriophage
    ¹ÚÅ׸®¿ÀÆäÀÌÁö
  • bacteriophage packaging
    ¹ÚÅ׸®¿ÀÆäÀÌÁö ÆÑÄÉ¡
  • acquired immunity
    "ȹµæ¸é¿ª (üòÔðØóæ¹), ÈÄõ¸é¿ª (ý­ô¸Øóæ¹)"
  • active immunity
    ´Éµ¿¸é¿ª(ÒöÔÑØóæ¹)
  • adoptive immunity
    ¾çÀڸ鿪(å×í­Øóæ¹)
  • cell-mediated immunity
    ¼¼Æ÷¸Å°³¸é¿ª(á¬øàØÚË¿Øóæ¹)
  • cellular immunity
    ¼¼Æ÷¸é¿ª(á¬øàØóæ¹)
  • immunity
    ¸é¿ª(Øóæ¹)
  • inherited immunity
    À¯Àü¸é¿ª(ë¶îîØóæ¹)
  • innate immunity
    "ÀÚ¿¬¸é¿ª(í»æÔØóæ¹), ¼±Ãµ¸é¿ª(à»ô¸Øóæ¹)"
  • lysogenic immunity
    ¿ë¿ø¸é¿ª(éÁê«Øóæ¹)
  • native immunity
    ÀÚ¿¬¸é¿ª(í»æÔØóæ¹)
  • natural immunity
    ÀÚ¿¬¸é¿ª(í»æÔØóæ¹)
  • nonspecific immunity
    ºñƯÀÌ ¸é¿ª(Þª÷åì¶Øóæµ)
  • passive immunity
    ¼öµ¿¸é¿ª(áôÔÑØóæ¹)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immunity
    ¸é¿ª¼º
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CMI   1) Cornell Medical Index
  2) Cell-Mediated Immunity
CI cardiac index; cardiac insufficiency; cell immunity; cell inhibition; cephalic index; cerebral infar...
CIDS cellular immunity deficiency syndrome; circular intensity differential scattering; continuous insuli...
CMI carbohydrate metabolism index; care management integration; case mix index; cell-mediated immunity; ...
HI half-scan with interpolation; head injury; health insurance; hearing impaired; heart infusion; hemag...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
CMI Cell mediated immunity
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • bacteriophage neutralization test
    ¹ÚÅ׸®¿À ÆÄ¾ÆÁö ÁßÈ­ ½ÃÇè
  • absolute immunity
    Àý´ë ¸é¿ª
  • active immunity
    ´Éµ¿ ¸é¿ª
    Ç׿ø Àڱؿ¡ ¹ÝÀÀÇÏ¿© »ý»êµÈ Ç×ü³ª ¸é¿ª ¸²ÇÁ°è ¼¼Æ÷ÀÇ Á¸Àç·Î ÀÎÇÑ È¹µæ¸é¿ª. »ç¶÷¿¡ ´ëÇØ¼­ ¹é½ÅÀ̳ª µ¶¼ºÀ¸·Î ¸é¿ªÇÏ´Â °ÍÀ¸·Î ÀÚ½ÅÀÇ ¸öÀ¸·Î ¸é¿ªÀ» ¸¸µé¾î³»¹Ç·Î È¿°ú´Â ¿À·¡ Áö¼ÓµÈ´Ù.
  • adoptive immunity
    ÀÔ¾ç ¸é¿ª
    µ¿Á¾ À̽Ä. ¿¹¸¦ µé¸é ¸¶¿ì½ºÀÇ ÇǺΠÀ̽ÄÀ» Çϸé ÀÌ½Ä ÈÄ 10ÀÏ Á¤µµ¿¡¼­ ÀÌ½ÄÆíÀº Å»¶ôÇÏ°í ¼ÒÀ§ °ÅºÎ Çö»óÀÌ ³ªÅ¸³­´Ù. ÀÌ ¸¶¿ì½º¿¡¼­ ¸²ÇÁ±¸¸¦ ¶¼¼­ ±×°ÍÀ» ¹Ìó¸® µ¿°è ¸¶¿ì½º·Î ÀÌÀÔÇÏ°í ±× µ¿¹°¿¡ ÃÖÃÊÀÇ ÇǺΠÀ̽İú °°Àº ÇǺθ¦ À̽ÄÇØÁÖ¸é ÀÌ °æ¿ìµµ °­ÇÑ °ÅºÎ ¹ÝÀÀÀÌ Àüº¸´Ùµµ »¡¸® ÀϾ¸ç À̽ÄÈÄ 3-4ÀÏ·Î ÀÌ½ÄÆíÀÇ ÆÄ±«°¡ ³ªÅ¸³­´Ù. À̰ÍÀº °ÅºÎ Çö»óÀÌ ¸é¿ª ¹ÝÀÀ¿¡ ÀÇÇØ¼­ ÀϾ´Ù´Â °ÍÀ» ÀǹÌÇÑ´Ù. ÀÌ¿Í °°ÀÌ °¨ÀÛ ¸²ÇÁ±¸¿¡ ÀÇÇØ¼­ ¸é¿ª´ÉÀ» ´Ù¸¥ °³Ã¼·Î Àü´ÞÇÏ´Â °ÍÀ» ¾çÀÚ ¸é¿ªÀ̶ó ÇÑ´Ù.
  • allogenic immunity
    µ¿Á¾ ¸é¿ª
  • antiviral immunity
    Ç×¹ÙÀÌ·¯½º ¸é¿ª
  • cell mediated immunity
    ¼¼Æ÷ ¸Å°³ ¸é¿ª, ¼¼Æ÷ ¸Å°³¼º ¸é¿ª ÀÛ¿ë, ¼¼Æ÷¼º ¸é¿ª
    Ç׿øÀÌ T Àӯı¸¸¦ ÀÚ±ØÇÏ¸é ¸é¿ª ±Û·ÎºÒ¸°À» ÇÕ¼º ºÐºñÇÏ´Â °ÍÀÌ ¾Æ´Ï°í Àӯı¸ ÀÚ½ÅÀÌ Ç×ü·Î ÀÛ¿ëÇÏ´Â °¨ÀÛ Àӯı¸°¡ µÇ´Â °ÍÀÌ Ã¼¾×¼º ¸é¿ª°úÀÇ Â÷ÀÌ·Î, ü¾×¼º ¸é¿ªÀÌ ÁÖ·Î ±Þ¼º ¼¼±Õ¼º Áúȯ¿¡ ´ëÇÑ ¸é¿ª ±âÀüÀε¥ ºñÇØ¼­ ¼¼Æ÷¼º ¸é¿ªÀº ¸¸¼º ¼¼±Õ¼º Áúȯ, Á¶Á÷ À̽Ä, ¾Ï ¼¼Æ÷, °õÆÎÀÌ Áúȯ, ƯÈ÷ ¹ÙÀÌ·¯½º Áúȯ¿¡ ´ëÇÑ ¸é¿ª ±âÀüÀÌ´Ù.
  • cell-mediated immunity
    ¼¼Æ÷ ¸Å°³ ¸é¿ª, ¼¼Æ÷ ¸Å°³¼º ¸é¿ª
  • congenital immunity
    ¼±Ãµ¼º ¸é¿ª
  • histogenous immunity
    Á¶Á÷ ¸é¿ª
  • homologous immunity
    µ¿Á¾ ¸é¿ª
  • immunity deficiency
    ¸é¿ª °áÇÌ
    µ¿ÀǾî=immunodeficiency.
  • inborn immunity
    ¼±Ãµ¼º ¸é¿ª
    °³Ã¼ÀÇ À¯ÀüÀû ¼ÒÁú¿¡ ±âÀÎÇÏ´Â ¸é¿ª.
  • infection immunity
    °¨¿° ¸é¿ª
    ÀÌ¹Ì Ç׿øÀÌ °°°Å³ª °ü·ÃµÈ Ç׿øÀ» °¡Áø ¹Ì»ý¹°¿¡ ÀÇÇÑ ÁúȯÀÌ Á¸ÀçÇϱ⠶§¹®¿¡ Àç°¨¿°¿¡ ´ëÇÏ¿© ÀúÇ×·ÂÀÌ ÀÖ´Â »óÅÂ.
  • local immunity
    ±¹¼Ò ¸é¿ª
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
bacteriophage immunity The state induced in a bacterium by lysogenization, the lysogenic bacterium being insusceptible to further lysogenization or to a lytic cycle by a superinfecting bacteriophage, in contradistinction to bacteriophage resistance.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
bacteriophage <microbiology, virology> Viruses that have a specific affinity for and infect bacteria.
The bacteriophages that attack Escherichia coli are termed coliphages, examples of these are lambda phage and the T even phages, T2, T4 and T6. Basically, phages consist of a protein coat or capsid enclosing the genetic material, DNA or RNA, that is injected into the bacterium upon infection. In the case of virulent phages all synthesis of host DNA, RNA and proteins ceases and the phage genome is used to direct the synthesis of phage nucleic acids and proteins using the host's transcriptional and translational apparatus.
These phage components then self assemble to form new phage particles. The synthesis of a phage lysozyme leads to rupture of the bacterial cell wall releasing, typically 100-200 phage progeny.
The temperate phages, such as lambda, may also show this lytic cycle when they infect a cell, but more frequently they induce lysogeny.
The study of bacteriophages has been important for our understanding of gene structure and regulation. Lambda has been extensively used as a vector in recombinant DNA studies.
(15 Nov 1997)
bacteriophage 2 depolymerase <enzyme> Hydrolyzes glycolipoproteins and lipopolysaccharides; releases aminosugars
Registry number: EC 3.2.1.-
Synonym: phage 2 depolymerase
(26 Jun 1999)
bacteriophage lambda <microbiology, virology> A bacteriophage, or virus which infects bacteria, that infects E. Coli. It has a complex set of regulatory mechanisms to determine whether it will quietly insert its DNA into the bacterial genome to become dormant and to be reproduced whenever the bacterium reproduces (to lysogenize), or whether it will hijack the bacterium's cellular machinery to reproduce itself and prepare to infect more bacteria, causing the bacterium to self-destruct shortly after infection (to lyse).
Lambda is particularly useful to geneticists because parts of it can be used to introduce foreign DNA into the bacterial genome, it is a cloning vector.
(09 Oct 1997)
bacteriophage m13 <microbiology> A bacteriophage (a virus which infects bacteria) that has single-stranded DNA. It is used as a method of obtaining single strands of foreign DNA so that the foreign DNA can be sequenced (that is, the order of its nucleotide bases can be determined). It is also used in procedures to create mutations in vitro (in a test tube rather than within an organism).
(09 Oct 1997)
bacteriophage mu An unassigned species of temperate coliphage, in the family myoviridae, composed of a linear, double-stranded molecule of DNA, which is able to insert itself at random at any point on the host chromosome. It frequently causes a mutation by interrupting the continuity of the bacterial operon at the site of insertion.
(12 Dec 1998)
bacteriophage omicron x174 <microbiology> A bacteriophage (a virus that infects bacteria) which has as its genetic material DNA in single strands instead of the usual double strands. The virus is useful to those who study how DNA replicates.
(09 Oct 1997)
bacteriophage p1 An unassigned species of temperate bacteriophage in the family myoviridae which infects e. Coli. It is the largest of the coliphages and consists of double-stranded DNA, terminally redundant, and circularly permuted.
(12 Dec 1998)
bacteriophage p2 An unassigned species of temperate bacteriophage in the family myoviridae which infects e. Coli. It consists of linear double-stranded DNA with 19-base sticky ends.
(12 Dec 1998)
bacteriophage p22 An unassigned species of temperate bacteriophage in the family podoviridae that infects salmonella species. The genome consists of double-stranded DNA, terminally redundant, and circularly permuted.
(12 Dec 1998)
bacteriophage phi 6 Virulent bacteriophage and sole member of the genus cystovirus that infects pseudomonas species. The virion has a segmented genome consisting of three pieces of doubled-stranded DNA and also contains a unique lipid-containing membrane.
(12 Dec 1998)
bacteriophage phi x 174 The type species of the genus microvirus. A prototype of the small virulent DNA coliphages, it is composed of a single strand of supercoiled circular DNA, which on infection, is converted to a double-stranded replicative form by a host enzyme.
(12 Dec 1998)
bacteriophage plaque A clear circular zone in an otherwise confluent growth of bacteria on an agar surface resulting from bacterial lysis by bacterial viruses.
(05 Mar 2000)
bacteriophage resistance Resistance of a bacterial mutant to infection by a bacteriophage to which the parent (wild type) strain is susceptible.
(05 Mar 2000)
bacteriophage t3 Bacteriophage in the genus t7-like phages, of the family podoviridae, which is very closely related to bacteriophage t7.
(12 Dec 1998)
bacteriophage T3 RNA polymerase <enzyme> Used for the rapid generation of strand-specific RNA molecules that can be used for the identification of genes in hybridization experiments
Registry number: EC 2.7.7.-
Synonym: t3 RNA polymerase
(26 Jun 1999)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bacteriophage
    (Àå,¿ÀÁÜ,ÇǼÓÀÇ)»ì±Õ¼Ò
  • immunity
    ¸é¿ª
  • cell-mediated immunity
    ¼¼Æ÷(¸Å°³)¼º ¸é¿ª(¼¼Æ÷¸·¿¡ ºÎÂøÇÏ´Â Ç×üÀÇ Á߻꿡 ÀÇÇÑ
  • cross-immunity
    ±³Â÷ ¸é¿ª(º´¿ø±Õ°ú À¯¼Ó±ÕÀÇ ¸é¿ª)
  • diplomatic immunity
    ¿Ü±³°ü ¸éÃ¥ Ư±Ç
  • immunity
    (Ã¥ÀÓ,Àǹ«µîÀÇ)¸éÁ¦;ƯÀü;(Àü¿°º´ µî¿¡ ´ëÇÑ)¸é¿ª¼º;¸é¿ªÁú;(±³È¸ÀÇ ¼¼¼ÓÀû Àǹ«ÀÇ)¸éÁ¦
  • immunity bath
    ¸éÃ¥;Ư±Ç;±â¼Ò(¼ÒÃß)¸éÁ¦;(Áõ¾ðÀ» ¾ò±â À§ÇØ ÁõÀο¡ ´ëÇÑ ±â¼Ò¸¦ ¸éÁ¦ÇÔ
  • passive immunity
    ¼öµ¿ ¸é¿ª
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á